Health-related quality of life evaluated by Pediatric Quality of Life Inventory 4.0 in pediatric leprosy patients with musculoskeletal manifestations

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorNEDER, Luciana
dc.contributor.authorWEELDEN, Marlon van
dc.contributor.authorVIOLA, Gabriela Ribeiro
dc.contributor.authorLOURENCO, Daniela Mencaroni
dc.contributor.authorLEN, Claudio A.
dc.contributor.authorSILVA, Clovis A.
dc.date.accessioned2015-12-10T16:48:42Z
dc.date.available2015-12-10T16:48:42Z
dc.date.issued2015
dc.description.abstractObjective: To evaluate the health-related quality of life (HRQL) in pediatric leprosy patients. Methods: A cross-sectional study included 47 leprosy patients and 45 healthy subjects. The HRQL was measured by Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0), and evaluated physical, emotional, social and school domains. The leprosy patients were classified by Ridley and Jopling classification criteria and assessed according to clinical musculoskeletal manifestations, laboratory and radiographic examinations. Results: The median of current age was similar in leprosy patients and controls [12(6-18) vs. 15(5-18) years, p = 0.384], likewise the frequencies of female gender (p = 0.835) and middle/lower Brazilian socio-economic classes (p = 1.0). The domain school activities according the child-self report was significantly lower in leprosy patients compared to controls in the age group of 13-18 years [75(45-100) vs. 90(45-100), p = 0.021]. The other domains were alike in both groups (p > 0.05). At least one musculoskeletal manifestation (arthralgia, arthritis and/or myalgia) was observed in 15% of leprosy patients and none in controls (p = 0.012). Further comparison between all leprosy patients showed that the median of the physical capacity domain [81.25(50-100) vs. 98.44(50-100), p = 0.036] and school activities domain by child-self report [60(50-85) vs. 80(45-100), p = 0.042] were significantly lower in patients with musculoskeletal manifestations compared to patients without these manifestations. No differences were evidenced between the other HRQL parameters in both groups, reported by patients and parents (p > 0.05). Conclusions: Reduced physical capacity and school activities domains were observed in pediatric leprosy patients with musculoskeletal manifestations.
dc.description.abstractObjetivo: Avaliar a qualidade de vida relacionada à saúde (QVRS) em pacientes pediátricos com hanseníase. Métodos: Estudo transversal com 47 pacientes com hanseníase e 45 indivíduos saudáveis. A QVRS foi mensurada pelo Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0) e os domí- nios físico, emocional, social e escolar foram avaliados. Os pacientes com hanseníase foram classificados pelos critérios de Ridley e Jopling e avaliados de acordo com manifestac¸ões clínicas musculoesqueléticas, laboratoriais e exames radiográficos. Resultados: A média de idade atual foi similar em pacientes com hanseníase e controles [12(6-18) vs. 15(5-18) anos, p = 0,384], assim como frequências do sexo feminino (p = 0,835) e classes socioeconômicas brasileiras média/baixa (p = 1,0). De acordo com a autoavaliac¸ão da crianc¸a relacionada com as atividades escolares, esse domínio foi significativamente menor nos pacientes com hanseníase em relac¸ão aos controles de 13-18 anos [75(45-100) vs. 90(45-100), p = 0,021]. Os outros domínios foram semelhantes em ambos os grupos (p > 0,05). Pelo menos uma manifestac¸ão musculoesquelética (artralgia, artrite e/ou mialgia) foi observada em 15% dos pacientes com hanseníase e nenhuma nos controles (p = 0,012). Uma comparac¸ão mais detalhada entre pacientes com hanseníase mostrou que a mediana do domínio de capacidade física [81,25(50-100) vs. 98,44(50-100), p = 0,036] e de atividades escolares pela autoavaliac¸ão da crianc¸a [60(50-85) vs. 80(45-100), p = 0,042] era significantemente menor nos pacientes com manifestac¸ões musculoesqueléticas em comparac¸ão com a dos pacientes sem essas manifestac¸ões. (1) Nenhuma diferenc¸a foi evidenciada entre os outros parâmetros de QVRS em ambos os grupos relatados pelos pacientes e pais (p > 0,05).
dc.description.indexMEDLINE
dc.identifier.citationREVISTA BRASILEIRA DE REUMATOLOGIA, v.55, n.5, p.414-419, 2015
dc.identifier.doi10.1016/j.rbr.2014.12.013
dc.identifier.issn0482-5004
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/12431
dc.language.isopor
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofRevista Brasileira de Reumatologia
dc.rightsopenAccess
dc.rights.holderCopyright ELSEVIER SCIENCE INC
dc.subjectLeprosy
dc.subjectChildren
dc.subjectHansen's disease
dc.subjectHealth-related quality of life
dc.subjectArthritis
dc.subjectLepra
dc.subjectCriança
dc.subjectHanseníase
dc.subjectQualidade de vida relacionada à saúde
dc.subjectArtrite
dc.subject.otheradolescents
dc.subject.otherarthritis
dc.subject.otherchildren
dc.subject.wosRheumatology
dc.titleHealth-related quality of life evaluated by Pediatric Quality of Life Inventory 4.0 in pediatric leprosy patients with musculoskeletal manifestations
dc.title.alternativeQualidade de vida relacionada à saúde avaliada pelo Inventário Pediátrico de Qualidade de Vida 4.0 em pacientes pediátricos com hanseníase e manifestac¸ões musculoesqueléticas
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalNEDER, Luciana:Univ Fed Mato Grosso, Serv Dermatol, Cuiaba, MT, Brazil
hcfmusp.author.externalLEN, Claudio A.:Univ Fed Sao Paulo Unifesp, Unidade Reumatol Pediat, Sao Paulo, SP, Brazil
hcfmusp.citation.scopus6
hcfmusp.contributor.author-fmusphcGABRIELA RIBEIRO VIOLA FERREIRA
hcfmusp.contributor.author-fmusphcDANIELA MENCARONI RODRIGUES LOURENCO
hcfmusp.contributor.author-fmusphcCLOVIS ARTUR ALMEIDA DA SILVA
hcfmusp.description.beginpage414
hcfmusp.description.endpage419
hcfmusp.description.issue5
hcfmusp.description.volume55
hcfmusp.origemWOS
hcfmusp.origem.pubmed26144576
hcfmusp.origem.scieloSCIELO:S0482-50042015000500414
hcfmusp.origem.scopus2-s2.0-85044146559
hcfmusp.origem.wosWOS:000362288400005
hcfmusp.publisher.cityNEW YORK
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAbdul-Sattar AB, 2014, RHEUMATOL INT, V34, P1095
hcfmusp.relation.referenceAlmeida PM, 1991, CRITERIO CLASSE EC A, P1
hcfmusp.relation.referencePereira HLA, 2009, CLIN RHEUMATOL, V28, P79, DOI 10.1007/s10067-008-0986-x
hcfmusp.relation.referenceKing S, 2011, PAIN, V152, P2729, DOI 10.1016/j.pain.2011.07.016
hcfmusp.relation.reference[Anonymous], 2013, WKLY EPIDEMIOL REC, V88, P365
hcfmusp.relation.referenceTerreri MTA, 1997, J TROP PEDIATRICS, V43, P186, DOI 10.1093/tropej/43.3.186
hcfmusp.relation.referenceAl-Raqum HA, 2006, CLIN RHEUMATOL, V25, P101, DOI 10.1007/s10067-005-1147-0
hcfmusp.relation.referenceKaur MR, 2007, CLIN EXP DERMATOL, V32, P784, DOI 10.1111/j.1365-2230.2007.02525.x
hcfmusp.relation.referenceMiladi MI, 2006, JOINT BONE SPINE, V73, P314, DOI 10.1016/j.jbspin.2005.03.014
hcfmusp.relation.reference[Anonymous], 2002, GUIA CONTR HANS
hcfmusp.relation.referenceGIBSON T, 1994, BRIT J RHEUMATOL, V33, P963
hcfmusp.relation.referenceNaughton MJ, 2014, J PEDIATR-US, V164, P1376, DOI 10.1016/j.jpeds.2014.01.027
hcfmusp.relation.referenceAbedi Heidarali, 2013, Pak J Biol Sci, V16, P927
hcfmusp.relation.referenceGuedes DP, 2014, REV PANAM SALUD PUBL, V35, P46
hcfmusp.relation.referenceATKIN SL, 1989, BRIT MED J, V298, P1423
hcfmusp.relation.referenceBharath S, 2001, Indian J Lepr, V73, P217
hcfmusp.relation.referenceChatterjee R N, 1989, Indian J Psychiatry, V31, P315
hcfmusp.relation.referenceChauhan S, 2010, RHEMATOLOGY OXFORD, V49, P2737
hcfmusp.relation.referenceGuidelines for the Control of Leprosy in the Northern territory. Department of Health and families, 2010, GUID CONTR LEPR NO T
hcfmusp.relation.referenceMenezes Adeline Soraya de O da P, 2013, Rev Paul Pediatr, V31, P24, DOI 10.1590/S0103-05822013000100005
hcfmusp.relation.referenceMoulick A, 2013, Indian J Lepr, V85, P83
hcfmusp.relation.referenceNeder L, 2014, J PEDIAT-BRAZIL, V90, P457, DOI 10.1016/j.jped.2014.01.007
hcfmusp.relation.referenceRidley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
hcfmusp.relation.referenceSihombing B, 2012, GLOB HLTH ACTION, P5
hcfmusp.relation.referencevan Brakel WH, 2003, INT J LEPROSY, V71, P190, DOI 10.1489/1544-581X(2003)71<190:MLSPRO>2.0.CO;2
hcfmusp.relation.referenceVarni James W., PEDSQL MEASUREMENT M
hcfmusp.relation.referenceVarni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-43
hcfmusp.relation.referenceWatanabe Hiroyuki, 2013, Nihon Hansenbyo Gakkai Zasshi, V82, P83
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication8af32506-3589-42cd-a1f5-e51c409c980b
relation.isAuthorOfPublicationa9ffd153-82c7-40f2-bcbb-b55d2fe5017c
relation.isAuthorOfPublication6c3c5459-9dbb-4a5c-98b1-d7b76943b87d
relation.isAuthorOfPublication.latestForDiscovery8af32506-3589-42cd-a1f5-e51c409c980b
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_NEDER_Healthrelated_quality_of_life_evaluated_by_Pediatric_Quality_2015.PDF
Tamanho:
512.7 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/36
Artigos e Materiais de Revistas Científicas - ODS/03